GUARDANT HEALTH INC (GH)

GHCL reported a thirty-two percent profit increase for the first quarter. Lower expenses helped boost net profit to Rs 191.18 crore from Rs 144.78 crore. Total income fell three point zero six percent while total expenses declined. New projects are nearing commercial operations in the second ...

Guardant Health jumped 6.3% to about US$162, and that pop highlights today’s sentiment tug of war. The stock came in after a flat week and a rough month, yet traders quickly latched onto one thing. Q2 revenue reached about US$335 million, with Screening revenue climbing to US$53 million as ...

Guardant Health (GH) stock jumps as the company announces Q2 2026 results, raising its full-year revenue outlook. Read more here.

Although the revenue and EPS for Guardant Health (GH) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

On the same day, Citi initiated coverage of the stock at Buy with a $215 price target, adding a fresh layer of institutional endorsement that amplified the positive earnings reaction. The broader market provided a mildly constructive but largely neutral backdrop, with the S&P 500 gaining 0.2% and th…